InvestorsHub Logo

pointofreturn

01/16/15 3:41 PM

#19917 RE: diamond482 #19914

Titan is under capitalized to get to market with SPORT, but a lot can and will happen between now and then. I'm in the camp that the PPS will be supported by management and Sherry Bertner. Not only through keeping the market more informed and her institutional contacts, but also by Titan forming strategic partnerships with others in the industry for development.

I actually think the next grow catalyst will be when the design freeze occurs ("Design and test of feasibility prototype complete" Q1 2015). The freeze signifies when detailed design phase has been completed and at which point the final version of the technical drawings are signed off and released to production.

So, when the design is frozen the product can be manufactured - there will be no more changes to the design of the machine at that point (unless it's changes like safety issues or problem corrections). Further cost reductions that are discovered will have to be implemented in the next product generation.

I think that the significance of that shouldn't be understated, and the market will react if/when they accomplish this milestone on time.

You commented on how management can be trusted, and I can't argue with that, when twice now they've changed course - you'll have to make a judgement call on that. Our friend CUIN is not happy and has mentioned that next time there is share appreciation he's going to look for an exit. It's unfortunate, however he is not alone in feeling this way, all longs must to some degree, and I respectfully understand their decisions.

However, when the design is frozen the next stages are all in Ximedica and Dr. Fowler's hands, and I believe that they are both extremely capable.

The next milestone will be engineering completion Q4 2015, and Titan can start showcasing its machines in participant hospitals for clinical trials. Word will spread quickly if it's the machine that we all believe it will be, so I think that a lot will happen before human clinical trials. Yes, money is an issue, but there will be opportunities to support PPS and get the warrants exercised if management stays the course here and meets milestones on time or early.

Honeycomb777

01/16/15 8:54 PM

#19928 RE: diamond482 #19914

Thx Diamond - there are so many people confused, dejected, demoralized, and on the verge of selling. There really are only 2 ways it can go:

1) They change course and show a tangible commitment to their shareholders

2) More excuses, stall tactics, and/or silent treatment and they lose 80% of their base. Why not wait to see how it goes as the next catalyst should come sometime in that 3/15 - 3/25 window BUT it is what they do (or not) next that will seal their fate IMO. We will all know by April 30th IMO as to what trajectory their on


* PPS can rise fast and go down just as fast. Their smart enough to know that there is no margin for error over the next several months. I still expect it to dip near term before a steady rise in anticipation of the Q1 milestone news. Earnings in Feb do nothing as we all know that their cash on hand will not be all that favorable. Remember it was 35 mil at the end of NOVEMBER